Journey Medical Corporation (DERM)
DERM moved a median of 0.00% 30 minutes after news, and +0.32% by the close. How DERM actually reacts to news — the realized, point-in-time move the market made, measured across 208 labeled events over the last three years with zero look-ahead.
DERM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 28% | 189 |
| 30-min | 0.00% | 50% | 206 |
| 60-min | 0.00% | 46% | 207 |
| to close | +0.32% | 54% | 204 |
| Middle 50% of DERM reactions | -1.71% to +1.40% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 208 |
Half of all Journey Medical Corporation news events land between -1.71% and +1.40% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How DERM reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 15 | +0.34% | 53% | -0.85% |
| Rating reiterations | 10 | -1.03% | 10% | -3.25% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how DERM ranks against every other measured name →
That’s how DERM usually reacts — get an email when it moves on news →Email me when DERM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to DERM's baseline. Nothing else.
Recent DERM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Journey Medical Corporation to Participate in September 2026 Investor Conferences | Press release | GlobeNewswire | +0.00% | -5.70% | |
| Form 10-Q Journey Medical Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.91% | -9.52% | |
| Form 8-K Journey Medical Corp For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | -1.91% | -9.52% | |
| Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -1.91% | -9.52% | |
| Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 | Press release | GlobeNewswire | +1.25% | -0.16% | |
| Form 8-K Journey Medical Corp For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +3.46% | +6.60% | |
| Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference | Press release | GlobeNewswire | -0.33% | +0.33% | |
| Form 10-Q Journey Medical Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.07% | +2.58% | |
| Form 8-K Journey Medical Corp For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +3.07% | +2.58% | |
| Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | +3.07% | +2.58% | |
| Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 | Press release | GlobeNewswire | +0.00% | -3.85% | |
| Form DEF 14A Journey Medical Corp For: Jun 24 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +1.37% | |
| Form DEFA14A Journey Medical Corp | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +1.37% | |
| Form 8-K Journey Medical Corp For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | -0.39% | -0.59% | |
| Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™ | Press release | GlobeNewswire | -2.29% | -6.29% | |
| Form 10-K Journey Medical Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.38% | -17.87% | |
| Form 8-K Journey Medical Corp For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | -1.38% | -17.87% | |
| Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -1.38% | -17.87% | |
| Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 | Press release | GlobeNewswire | +0.00% | -4.30% | |
| Form EFFECT Journey Medical Corp | SEC filing · Form EFFECT | SEC EDGAR | -0.22% | +4.51% | |
| Form S-3 Journey Medical Corp | SEC filing · Form S-3 | SEC EDGAR | -0.01% | -3.61% | |
| Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology | Press release | GlobeNewswire | +0.84% | -4.82% | |
| Form 10-Q Journey Medical Corp For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.97% | — | |
| Form 8-K Journey Medical Corp For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | -2.97% | — | |
| Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -2.97% | — | |
| Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 | Press release | GlobeNewswire | -0.22% | -1.78% | |
| Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference | Press release | GlobeNewswire | -0.73% | -1.58% | |
| Journey Medical Corporation to Participate in October 2025 Investor Conferences | Press release | GlobeNewswire | +0.00% | -0.13% | |
| Form 8-K Journey Medical Corp For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.42% | |
| Journey Medical Corporation to Participate in September 2025 Investor Conferences | Press release | GlobeNewswire | +1.42% | -1.42% | |
| Form 8-K Journey Medical Corp For: Aug 28 | SEC filing · Form 8-K | SEC EDGAR | -2.75% | -0.82% | |
| Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream | Press release | GlobeNewswire | +2.91% | — | |
| Journey Medical Corporation to Present at the Emerging Growth Conference | Press release | GlobeNewswire | -2.90% | +1.45% | |
| Form 10-Q Journey Medical Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.08% | -3.33% | |
| Form 8-K Journey Medical Corp For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | -5.08% | -3.33% | |
| Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -5.08% | -3.33% | |
| Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 | Press release | GlobeNewswire | +0.00% | +0.41% | |
| Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 | Press release | GlobeNewswire | — | +0.56% | |
| Form 8-K Journey Medical Corp For: Jul 14 | SEC filing · Form 8-K | SEC EDGAR | -0.68% | -5.68% | |
| Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™ | Press release | GlobeNewswire | +3.06% | +2.92% | |
| Form 8-K Journey Medical Corp For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.00% | |
| Form 8-K Journey Medical Corp For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | -0.36% | +1.02% | |
| Journey Medical to Join Russell 2000® and Russell 3000® Indexes | Press release | GlobeNewswire | -0.36% | +1.02% | |
| Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference | Press release | GlobeNewswire | — | +2.36% | |
| Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV | Press release | GlobeNewswire | -0.96% | -2.19% | |
| Form 10-Q Journey Medical Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +12.99% | +13.78% | |
| Form 8-K Journey Medical Corp For: May 14 | SEC filing · Form 8-K | SEC EDGAR | +12.99% | +13.78% | |
| Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | +12.99% | +13.78% | |
| Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 | Press release | GlobeNewswire | -1.01% | -0.72% | |
| Form DEF 14A Journey Medical Corp For: Jun 24 | SEC filing · Form DEF | SEC EDGAR | +1.56% | +0.41% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the DERM section they belong to.
Where else DERM is measured.
DERM earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | 209 | -0.82% | 38% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 208 | -0.32% | 48% |
| Windtree Therapeutics, Inc. (WINT) | 207 | -1.40% | 27% |
| Cronos Group Inc (CRON_TSE) | 206 | +0.15% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Journey Medical Corporation's median reaction calculated?
Every labeled DERM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 208 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of DERM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does DERM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.